The chemokine receptor antagonist TAK-779 attenuates atherogenesis

被引：0
|
作者：
van Wanroolj, EJA
Happe, H
de Vos, P
Fujiwara, H
Berkel, THJC
Kulper, J
机构：
[1] LACDR, Leiden, Netherlands
[2] Grad Sch Med, Osaka, Japan
来源：
CIRCULATION | 2004年 / 110卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
665
引用
收藏
页码：141 / 141
页数：1
相关论文
共 50 条
  • [31] Treatment with BX471, a CC chemokine receptor 1 antagonist, attenuates systemic inflammatory response during sepsis
    He, Min
    Horuk, Richard
    Moochhala, Shabbir M.
    Bhatia, Madhav
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2007, 292 (04): : G1173 - G1180
  • [32] Angiotensin-(1-7) antagonist A-779 attenuates the potentiation of bradykinin by captopril in rats
    Maia, LG
    Ramos, MC
    Fernandes, L
    De Carvalho, MHC
    Campagnole-Santos, MJ
    Dos Santos, RAS
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2004, 43 (05) : 685 - 691
  • [33] TLR4 antagonist attenuates atherogenesis in LDL receptor-deficient mice with diet-induced type 2 diabetes
    Lu, Zhongyang
    Zhang, Xiaoming
    Li, Yanchun
    Lopes-Virella, Maria F.
    Huang, Yan
    IMMUNOBIOLOGY, 2015, 220 (11) : 1246 - 1254
  • [34] S1p2 Receptor Antagonist Attenuates Endothelial Dysfunction and Inhibits Atherogenesis in Apolipoprotein-e-deficient Mice
    Ganbaatar, Byambasuren
    Fukuda, Daiju
    Yagi, Shusuke
    Kusunose, Kenya
    Yamada, Hirotsugu
    Soeki, Takeshi
    Sata, Masataka
    CIRCULATION, 2019, 140
  • [35] Inhibition of the proteasome attenuates atherogenesis in LDL-receptor-knockout mice
    Wilck, N.
    Fechner, M.
    Stangl, K.
    Stangl, V.
    Baumann, G.
    Ludwig, A.
    EUROPEAN HEART JOURNAL, 2008, 29 : 864 - 864
  • [36] Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist RevealsMechanisms of Chemokine Recognition and Molecular Mimicry by HIV
    Zheng, Yi
    Han, Gye Won
    Abagyan, Ruben
    Wu, Beili
    Stevens, Raymond C.
    Cherezov, Vadim
    Kufareva, Irina
    Handel, Tracy M.
    IMMUNITY, 2017, 46 (06) : 1005 - +
  • [37] A chemokine receptor antagonist inhibits experimental breast tumor growth
    Robinson, SC
    Scott, KA
    Wilson, JL
    Thompson, RG
    Proudfoot, AEI
    Balkwill, FR
    CANCER RESEARCH, 2003, 63 (23) : 8360 - 8365
  • [38] Danirixin: A Reversible and Selective Antagonist of the CXC Chemokine Receptor 2
    Busch-Petersen, Jakob
    Carpenter, Donald C.
    Burman, Miriam
    Foley, James
    Hunsberger, Gerald E.
    Kilian, David J.
    Salmon, Michael
    Mayer, Ruth J.
    Yonchuk, John G.
    Tal-Singer, Ruth
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2017, 362 (02): : 338 - 346
  • [39] Chemokine Receptor 7 Knockout Attenuates Atherosclerotic Plaque Development
    Luchtefeld, Maren
    Grothusen, Christina
    Gagalick, Andreas
    Jagavelu, Kumaravelu
    Schuett, Harald
    Tietge, Uwe J. F.
    Pabst, Oliver
    Grote, Karsten
    Drexler, Helmut
    Foerster, Reinhold
    Schieffer, Bernhard
    CIRCULATION, 2010, 122 (16) : 1621 - U166
  • [40] Atypical chemokine receptor 1 deficiency reduces atherogenesis in ApoE-knockout mice
    Wan, Wuzhou
    Liu, Qian
    Lionakis, Michail S.
    Marino, Ana Paula M. P.
    Anderson, Stasia A.
    Swamydas, Muthulekha
    Murphy, Philip M.
    CARDIOVASCULAR RESEARCH, 2015, 106 (03) : 478 - 487
12345